Gilead Sciences Contract with Customer, Liability decreased by 2.1% to $47.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.1%, from $56.00M to $47.00M. Over 5 years (FY 2020 to FY 2025), Contract with Customer, Liability shows a downward trend with a -13.1% CAGR.
An increase indicates higher deferred revenue and future service obligations, while a decrease suggests revenue is being recognized faster than new prepayments are received.
This represents the obligation to transfer services to a customer for which the entity has received consideration or for...
Similar to deferred revenue or contract liabilities reported by other asset management and financial services companies.
other_contract_with_customer_liability| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.00M | $85.00M | $79.00M | $117.00M | $98.00M | $85.00M | $102.00M | $93.00M | $103.00M | $68.00M | $109.00M | $84.00M | $76.00M | $68.00M | $58.00M | $56.00M | $58.00M | $56.00M | $48.00M | $47.00M |
| QoQ Change | — | -2.3% | -7.1% | +48.1% | -16.2% | -13.3% | +20.0% | -8.8% | +10.8% | -34.0% | +60.3% | -22.9% | -9.5% | -10.5% | -14.7% | -3.4% | +3.6% | -3.4% | -14.3% | -2.1% |
| YoY Change | — | — | — | — | +12.6% | +0.0% | +29.1% | -20.5% | +5.1% | -20.0% | +6.9% | -9.7% | -26.2% | +0.0% | -46.8% | -33.3% | -23.7% | -17.6% | -17.2% | -16.1% |